H. Lundbeck A/S Newsletter
-
Anxiety Disorders and Depression Treatment Market Growth and Company Analysis Report 2025-2033 Featuring Abbvie, BMS, Eli Lily & Co, GSK, H. Lundbeck, J&J, Merck, Pfizer, Sanofi-Aventis, Axsome – ResearchAndMarkets.com
12 Sep 2025 17:13 GMT
… Lily & Co
GlaxoSmithKline
H. Lundbeck A/S
Johnson …
-
‘Promising’ new data could change treatment landscape for some rare diseases
16 Sep 2025 19:36 GMT
… research support from Crinetics, H. Lundbeck, Neurocrine Biosciences, Neurocrine UK and … ties with Corcept Therapeutics, Ipsen, Lundbeck, Merck, Novo Nordisk and Pfizer …
-
Epilepsy Treatment Market to Reach USD 8.10 Billion by 2032 Industry Growth Driven by Rising Healthcare Investments
16 Sep 2025 13:18 GMT
… .ESTEVE
26.Zogenix Inc.
27.Lundbeck
28.Supernus Pharmaceuticals Inc
29 …
-
Global Psychotic Disorders Market Poised For Significant Growth
16 Sep 2025 09:25 GMT
… -Myers Squibb, Eli Lilly, H. Lundbeck A/S, Johnson …
-
Key signature sets Parkinson’s and essential tremor apart
16 Sep 2025 01:00 GMT
… . Additional support came from the Lundbeck Foundation and the Red Gates …
-
Tardive Dyskinesia Treatment Global Market Report 2025| Business Growth, Current and Future Trends till 2029
15 Sep 2025 02:00 GMT
…
• Kyowa Kirin Co Ltd.
• H. Lundbeck A/S
• Zydus Lifesciences …
-
Fierce Pharma Asia—Crackdown on China licensing deals?; Daiichi, Merck's ADC win; Sun's import ban
12 Sep 2025 13:21 GMT
… its founding in 2011.
5. Lundbeck, in major resource reallocation, bows … and lays off 602 staffers
Lundbeck is closing its commercial operations …
-
Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight
11 Sep 2025 17:00 GMT
… NRx Pharmaceuticals, LB Pharmaceuticals, Lundbeck, AbbVie, Autobahn Therapeutics, Alto … NRx Pharmaceuticals, LB Pharmaceuticals, Lundbeck, AbbVie, Autobahn Therapeutics, Alto … NRx Pharmaceuticals, LB Pharmaceuticals, Lundbeck, AbbVie, Autobahn Therapeutics, …
-
Pharmaceutical Executive Daily: September 11, 2025
11 Sep 2025 20:34 GMT
… Pharmaceutical Executive Daily, we cover Lundbeck’s restructuring affecting more than … pharmaceutical direct-to-consumer advertising.
Lundbeck has announced a significant restructuring …
-
Defective Exosome Production Linked to Alzheimer’s Gene Mutation
11 Sep 2025 22:27 GMT
… LF postdoctoral grant from the Lundbeck Foundation (R380-2021-1326) awarded …